US Patent 11945868 Antibody molecules to CD138 and uses thereof
Patent 11945868 was granted and assigned to Visterra Inc. on April, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11945868 Antibody molecules to CD138 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
